Florida s Risk Management Program State Workers Compensation Program Cost Drivers Presentation to the Senate Budget Committee November 16, 2011

Similar documents
Florida Workers Compensation Market 2012

THREE-MEMBER PANEL 2017 EDITION. Biennial Report. Presented January of 50

80th OREGON LEGISLATIVE ASSEMBLY Regular Session. House Bill Sponsored by Representative NOSSE; Representative SANCHEZ (Presession filed.

NCCI Rate Filing. October 1, Additionally, pursuant to your Order, the reduced rates will apply to all

Workers Compensation Board Pharmacy Benefit Plan

Inside: Critical information about your company s prescription drug benefit.

79th OREGON LEGISLATIVE ASSEMBLY Regular Session. House Bill 4005

THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL INTRODUCED BY WHITE, STREET, BARTOLOTTA, COSTA, FONTANA AND BREWSTER, APRIL 18, 2017 AN ACT

NATIONAL COUNCIL OF INSURANCE LEGISLATORS (NCOIL) Workers Compensation Pharmaceutical Reimbursement Rates Model Act

Texas Vendor Drug Program. Drug Addition Process. Effective Date. December 2017

Rate Component Overview

Understanding Pharmacy Benefit Management Services

BERKELEY RESEARCH GROUP. Executive Summary

DEPARTMENT OF FINANCIAL SERVICES DIVISION OF WORKERS COMPENSATION

Florida Medicaid Prescribed Drug Service Spending Control Initiatives

The Florida Legislature

Department of Financial Services Division of Risk Management FISCAL YEAR 2013 ANNUAL REPORT

Health Benefits Briefing

AN ACT TO ESTABLISH RATE SETTING OF PRESCRIPTION DRUGS IN [STATE]

CRS Report for Congress Received through the CRS Web

H 5323 S T A T E O F R H O D E I S L A N D

Prescription Drug Coverage

NATIONAL COUNCILCONFERENCE OF INSURANCE LEGISLATORS (NCOIL) Model Act on Workers Compensation Repackaged Pharmaceutical Reimbursement Rates Model Act

Florida Medicaid Prescribed Drug Service Spending Control Initiatives. For the Quarter April 1, 2016 through June 30, 2016

Florida Medicaid Prescribed Drug Service Spending Control Initiatives. For the Quarter July 1, 2016 through September 30, 2016

The Impact of the Medicare Prescription Drug Legislation on Pharmaceutical Revenues

RESEARCH UPDATE. Analysis of California Workers Compensation Reforms

CHAPTER 58-29E PHARMACY BENEFITS MANAGEMENT

Medical Call Data Validation

INDUSTRY PERSPECTIVE. Quick Reference Data Current as of July 2015

Prescription Drugs Spending Distribution and Cost Drivers. Steve Kappel January 25, 2007

NCPDP Electronic Prescribing Standards

KEEPING PRESCRIPTION DRUGS AFFORDABLE: The Value of Pharmacy Benefit Managers (PBMs)

Pharmacy Benefit Managers Overview

Medicaid Prescribed Drug Program Spending Control Initiatives. For the Quarter April 1, 2014 through June 30, 2014

3. Prescription Drug Plan Options

Department of Management Services REQUEST FOR INFORMATION. Comprehensive Surgical and Medical Procedures Entity

CHAPTER Senate Bill No. 2508

SECTION 8. EMPLOYEE COMPENSATION AND BENEFITS - FISCAL YEAR

79th OREGON LEGISLATIVE ASSEMBLY Regular Session. House Bill Corrected Sponsor

Covis Pharmaceuticals, Inc. Patient Assistance Program

STATE OF NEW JERSEY. SENATE, No th LEGISLATURE. Sponsored by: Senator NIA H. GILL District 34 (Essex and Passaic)

House Bill 2387 Ordered by the House April 27 Including House Amendments dated April 27

HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR

The Florida Senate. Interim Project Summary November 2001 HOW DOES THE WORKERS' COMPENSATION SYSTEM IN FLORIDA COMPARE TO OTHER STATES?

ASSEMBLY, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED JULY 11, 2014

Evaluation of Savings from Pharmaceutical Interventions. Robin Lunge Steve Kappel January 26, 2007

A Bill Regular Session, 2011 SENATE BILL 839

INTERNAL AUDIT DEPARTMENT

340B Pharmacy Program Compliance insight. ideas Kentucky Primary Care Association attention

Pharmacy Billing and Reimbursement

Proposed MAC Legislation May Increase Costs Of Affected Generic Drugs By More Than 50 Percent. Prepared for

PENNSYLVANIA COMPENSATION RATING BUREAU. Evaluation of House Bill 1846 of 2014 (HB1846)

Proposed MAC Legislation May Increase Costs of Affected Generic Drugs By More Than 50 Percent. Prepared for

Subcommittee on Health and Human Services Government Efficiency Task Force 401 Senate Office Building April 3, :00 a.m. 11:00 a.m.

PBM MODEL A A MODEL ACT RELATING TO PHARMACY BENEFIT MANAGERS*

HEATHER I. BATES Managing Director, BRG Health Analytics. BERKELEY RESEARCH GROUP, LLC 1800 M Street NW, 2 nd Floor Washington, DC 20036

Common Managed Care Terms & Definitions

New York State WC Reform Update

Florida Medicaid Prescribed Drug Service Spending Control Initiatives. For the Quarter October 1, 2017 through December 31, 2017

Understanding the Consumer Driven Health Plan. and Health Savings Account

Department of Financial Services Division of Risk Management FISCAL YEAR 2012 ANNUAL REPORT

Public Employees Benefits Program Legislative Session Bill Tracking Updated: 3/27/2017

THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL INTRODUCED BY EICHELBERGER, ARGALL, RAFFERTY, VULAKOVICH AND BROWNE, MAY 18, 2018 AN ACT

The Challenge of Implementing Interoperable Electronic Medical Records

The Role of the Actuary in Employee Benefits

State Employees' Group Health Self-Insurance Trust Fund

Glossary of Terms (Terms are listed in Alphabetical Order)

Self-Administration Toolkit for Workers Compensation Medicare Set-Aside Arrangements (WCMSAs)

A Bill Regular Session, 2015 SENATE BILL 688

Annual Report on Cost Containment. Fiscal Year 2017

THIRD-PARTY PHARMACY RECONCILIATION

Flowchart: Sources of Drugs Dispensed to Kane Residents 5. II. Objectives, Scope, and Methodology 6

1/16/2014. David Pointer President, SolutionsRx

PROPOSED AMENDMENTS TO HOUSE BILL 2645

ANALYSIS OF FLORIDA WORKERS COMPENSATION RATE FILING PROPOSED EFFECTIVE 8/1/2016

2013 STATE LEGISLATIVE PROGRAM

1 SB By Senators Beasley, Smitherman, Irons, Bussman and Ross. 4 RFD: Health. 5 First Read: 12-APR-11. Page 0

2012 Medicare Part D Transition Process for contracts H3864 & H4754:

Lee County Board of County Commissioners Workers Compensation Procedures QUICK REFERENCE GUIDE

LITIGATING AWP. Mitch Lazris/Lyndon Tretter Hogan & Hartson L.L.P. November 15, 2002

COMPLIANCE IN THE 340B DRUG PRICING PROGRAM

Medicaid Prescribed Drug Program. Spending Control Initiatives

Authorized By: Richard J. Badolato, Commissioner, Department of Banking and Insurance.

TRS Update to TASPA 2015 Summer Conference

Intel Corporation Connected Care Arizona Care Network

Drug Reimbursement - Croatia. Roganovic Jelena

Prescription Drug Rider

OFFICE OF INSURANCE REGULATION

80th OREGON LEGISLATIVE ASSEMBLY Regular Session. Senate Bill 572

Prescription Drug Schedule of Benefits

Farm Bureau Select Rx 2017 Summary of Benefits January 1, December 31, 2017

Prescription Medication Schedule of Benefits

Moving From PBM to PBA Model

The Real Deal About Real-Time Benefits. Proven Savings with Up-to-the-Minute, Member-Specific Information Across Multiple Points of Care

Assure Card Deferred Reimbursement. Making the most of your benefits for plan members and their dependants

CDHP Special Administration

AETNA LIFE INSURANCE COMPANY

summary of benefits Blue Shield of California Medicare Rx Plan (PDP)

TouchScript Medication Management System. Financial Impact Analysis on Pharmacy Risk Pools

Transcription:

Florida s Risk Management Program State Workers Compensation Program Cost Drivers Presentation to the Senate Budget Committee November 16, 2011 Keeping your money in your pocket, where it belongs.

Risk Management Program Overview Florida s self-insurance program for property and casualty risks administered by the Department of Financial Services. The program was designed to administer certain claims of state agencies and provide them with loss prevention guidance. Accordingly, it covers the Executive, Legislative, and Judicial branches of Florida government, as well as the State Universities. The program is funded by yearly assessments to participating state agencies. 1 2

FY 2010-2011 DRM Total Expenditures of $199,532,231 by Major Category General Liability Losses, $4,879,748 DRM Non-Allocated Operating Expenses, $6,513,027 WC Attorney Expenses, $7,023,149 Excess/Reinsurance Expenses, $8,938,816 DWC Assessments, $2,302,106 Automobile Liability Losses, $3,055,915 FCR Losses, $4,103,482 Court Awarded Attorney Fees, $389,183 Property Losses, $197,451 Workers Compensation Benefit Costs comprise about two-thirds of the costs for the State Risk Management Program. MCM & Vendor Expenses, $11,242,540 SLC Attorney Expenses, $13,365,201 Workers Compensation Losses, $111,996,010 $16 Million of the $111,996,010 in benefit costs was spent on pharmacy benefits. Loan Repayments and Refunds/Fees, $25,525,603 2 3

Workers Compensation Benefit Payments for the Last Three Fiscal Years FY 2008-2009: 13,842 new claims reported and $109,646,128 in loss payments FY 2009-2010: 14,900 new claims reported and $118,915,603 in loss payments FY 2010-2011: 14,367 new claims reported and $111,996,010 in loss payments 3 4

Specific Claims Cost Drivers 1. Rising medical costs including pharmaceutical costs: Repackaged drugs increase pharmacy and administrative costs necessary to address billing for repackaged drugs. 2. Substantially lower recoveries on claims: These have decreased from $19.2M in FY 2007-2008, to $4.4M in FY 2009-2010, and $7.2M in FY 2010-2011. 3. Current law: Presumption Claims (112.18, F.S.), have accounted for over $30M in additional costs since implementation of this law in 2003. 4. Mandated Cost of Living supplement on Permanent Total Disability (PTD) claims of 3-5% per year. 5. Occasional and unexpected large awards for civil rights violation claims. 4 5

Drug Repackaging DFS Division of Workers Compensation serves as a compliance resource for stakeholders, administers and oversees the provisions of Chapter 440, F.S., and provides real-time workers comp information. Over the last couple of years, drug repackaging has become a hot topic in the workers compensation insurance marketplace. Drug repackagers are currently licensed by the Department of Business and Professional Regulation. Current law allows prescription drugs to be reimbursed at the average wholesale price (AWP) plus a $4.18 dispensing fee, or a contract rate, whichever is lower. There is no uniform definition of AWP. Although drug repackagers do not alter the drugs, they do sell them in different quantities. In doing so, a new AWP is assigned. In 2010, HB 5603 was vetoed by Gov. Crist. That bill would have continued to allow the repackaging of prescription drugs, but it strictly limited the reimbursement amount to the AWP of the original manufacturer, plus the $4.18 dispensing fee. 5 6

The National Council on Compensation Insurance (NCCI)*, estimated that HB 5603 (2010) would have decreased overall workers comp costs by 1.1%, or $34 million, in Florida. Drug Repackaging, continued Last session, SB 1068 (2011) similarly revised requirements for determining the reimbursement amount for repackaged drugs for workers compensation claimants. It limited the reimbursement amount for a repackaged drug by multiplying the number of units dispensed by the per-unit AWP set by the original manufacturer, plus a $ 4.18 dispensing fee, or the contracted rate negotiated by DMS. NCCI estimated that SB 1068 would have had a -2.5% impact, or in other words, would have saved over $60 million in workers comp costs. 6 * NCCI manages the largest database of workers comp insurance information. In Florida, NCCI files for rates on behalf of workers comp insurers. 7

Repackaging vs. Dispensing: The Distinction Although related, dispensing and repackaging are distinct. Physician dispensing is the practice of providing prescription medication to patients in a doctor s office. This can offer a convenience to patients. Repackaging is the practice of assigning a different cost to the prescriptions by changing the quantity or label of the prescription. By relabeling or repackaging a prescription, a new National Drug Code is assigned, which triggers the assignment of a new and different AWP. Neither HB 5603 nor SB 1068 altered the ability of physicians to dispense; rather, they limited the associated costs of repackaging to the formula currently allowable for pharmacies. 7 8

Dispensing & Repackaging Costs NCCI published this illustration of price differentials between repackaged and nonrepackaged drugs. Again, this difference is typically due to the assignment of a new AWP. Our Division of Risk Management has previously estimated that the impact of repackaging reform to the State, based on its administration of workers compensation claims for state employees, would be approximately $400,000- $500,000/annually. A recent study of the Division of Risk Management s pharmacy costs reflects that actual costs associated with repackaged drugs have increased from $12K in 2008 to $1.2M in 2010. 8 9

The chart to the right shows physician dispensing of repackaged drugs for the Division of Risk Management. Since 2009, physicians have dispensed nearly 90% repackaged drugs. *Based on a study by HealthCare Solutions. 100% 80% 60% 40% 20% 0% 2007 2008 2009 2010 % Scripts Repackaged % Scripts Non-Repackaged Rx Dollars $1,400,000 $1,200,000 $1,000,000 $800,000 $600,000 $400,000 $200,000 $- 2006 2007 2008 2009 2010 Additionally, the chart to the left shows that costs associated with repackaged drugs borne by the Division have increased from $12,000 in 2008 to $1.2million in 2010. *Based on a study by HealthCare Solutions. 9 Cost from Repackaged Drugs Cost from Non-Repackaged Drugs 10

QUESTIONS? 11